Thursday, October 10, 2013

Oncogene - Table of Contents alert Volume 32 Issue 41

Oncogene

Advertisement
Expression of pluripotency transcription factors , epigenetic reprogramming, and tumor initiation in cancer 
Submission deadline: 01 Apr 2014

This Research Topic from Frontiers in Oncology aims to bring together the scientific community that investigates the molecular basis of cancer initiation, with focus on the role of pluripotency genes, and how the disrupted transcriptional and epigenomic network might lead to tumorigenesis and tumor progression. 

Find out more on how to contribute to this RT 
TABLE OF CONTENTS

Volume 32, Issue 41 (October 2013)

In this issue
Review
Commentary
Original Articles
Short Communication

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Oncogenesis wants to publish YOUR paper.

Oncogenesis is indexed in PubMed, PubMed Central, and the Directory of Open Access Journals, ensuring maximum discoverability of your research.
Author also benefit from:
- Open access
- Fast publication times
- Easy online submission process
- High exposure through Nature.com 

Submit your paper today! 

Review

Top

Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies

D Sia, V Tovar, A Moeini and J M Llovet

Oncogene 2013 32: 4861-4870; advance online publication, January 14, 2013; 10.1038/onc.2012.617

Abstract | Full Text

Commentary

Top

Claudin-1 as a promoter of EMT in hepatocellular carcinoma

J Stebbing, A Filipović and G Giamas

Oncogene 2013 32: 4871-4872; advance online publication, January 14, 2013; 10.1038/onc.2012.591

Abstract | Full Text

Original Articles

Top

Claudin-1 induces epithelial–mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells

Y Suh, C-H Yoon, R-K Kim, E-J Lim, Y S Oh, S-G Hwang, S An, G Yoon, M C Gye, J-M Yi, M-J Kim and S-J Lee

Oncogene 2013 32: 4873-4882; advance online publication, November 19, 2012; 10.1038/onc.2012.505

Abstract | Full Text

CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-α

S Li, M Wang, X Ao, A K Chang, C Yang, F Zhao, H Bi, Y Liu, L Xiao and H Wu

Oncogene 2013 32: 4883-4891; advance online publication, November 19, 2012; 10.1038/onc.2012.518

Abstract | Full Text

Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ OPEN

S Jin, A P Mutvei, I V Chivukula, E R Andersson, D Ramsköld, R Sandberg, K L Lee, P Kronqvist, V Mamaeva, P Östling, J-P Mpindi, O Kallioniemi, I Screpanti, L Poellinger, C Sahlgren and U Lendahl

Oncogene 2013 32: 4892-4902; advance online publication, November 26, 2012; 10.1038/onc.2012.517

Abstract | Full Text

Long interspersed element-1 is differentially regulated by food-borne carcinogens via the aryl hydrocarbon receptor OPEN

N Okudaira, T Okamura, M Tamura, K Iijma, M Goto, A Matsunaga, M Ochiai, H Nakagama, S Kano, Y Fujii-Kuriyama and Y Ishizaka

Oncogene 2013 32: 4903-4912; advance online publication, December 3, 2012; 10.1038/onc.2012.516

Abstract | Full Text

SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation

M Buchwald, K Pietschmann, P Brand, A Günther, N P Mahajan, T Heinzel and O H Krämer

Oncogene 2013 32: 4913-4920; advance online publication, December 3, 2012; 10.1038/onc.2012.515

Abstract | Full Text

Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78

H-Y Tsai, Y-F Yang, A T Wu, C-J Yang, Y-P Liu, Y-H Jan, C-H Lee, Y-W Hsiao, C-T Yeh, C-N Shen, P-J Lu, M-S Huang and M Hsiao

Oncogene 2013 32: 4921-4931; advance online publication, January 14, 2013; 10.1038/onc.2012.514

Abstract | Full Text

Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK

A Avivar-Valderas, E Bobrovnikova-Marjon, J Alan Diehl, N Bardeesy, J Debnath and J A Aguirre-Ghiso

Oncogene 2013 32: 4932-4940; advance online publication, November 19, 2012; 10.1038/onc.2012.512

Abstract | Full Text

The neural guidance receptor Plexin C1 delays melanoma progression

Y Chen, J Soong, S Mohanty, L Xu and G Scott

Oncogene 2013 32: 4941-4949; advance online publication, November 19, 2012; 10.1038/onc.2012.511

Abstract | Full Text

Inhibition of AHR transcription by NF1C is affected by a single-nucleotide polymorphism, and is involved in suppression of human uterine endometrial cancer

D Li, T Takao, R Tsunematsu, S Morokuma, K Fukushima, H Kobayashi, T Saito, M Furue, N Wake and K Asanoma

Oncogene 2013 32: 4950-4959; advance online publication, December 3, 2012; 10.1038/onc.2012.509

Abstract | Full Text

Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination

H J Choi, J Kim, K H Do, S-H Park and Y Moon

Oncogene 2013 32: 4960-4969; advance online publication, March 18, 2013; 10.1038/onc.2012.508

Abstract | Full Text

The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development

R Rubio, I Gutierrez-Aranda, A I Sáez-Castillo, A Labarga, M Rosu-Myles, S Gonzalez-Garcia, M L Toribio, P Menendez and R Rodriguez

Oncogene 2013 32: 4970-4980; advance online publication, December 10, 2012; 10.1038/onc.2012.507

Abstract | Full Text

Zipper-interacting protein kinase is involved in regulation of ubiquitination of the androgen receptor, thereby contributing to dynamic transcription complex assembly

A Felten, D Brinckmann, G Landsberg and K H Scheidtmann

Oncogene 2013 32: 4981-4988; advance online publication, November 12, 2012; 10.1038/onc.2012.503

Abstract | Full Text

Short Communication

Top

Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model

T Berger, T Ueda, E Arpaia, I I C Chio, E A Shirdel, I Jurisica, K Hamada, A You-Ten, J Haight, A Wakeham, C C Cheung and T W Mak

Oncogene 2012 32: 4989-4994; advance online publication, November 12, 2012; 10.1038/onc.2012.499

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: